Here are my favorite four biotech penny stocks to buy now: YM BioSciences (YMI): The first stock on the list is biopharmaceutical company YM BioSciences, which develops products for the treatment of cancer. In the last 12 months, YMI stock has gained …
The Street · 6/1/1985
Biotech penny stocks have a lot to offer investors ... YM BioSciences, Inc. YM BioSciences (AMEX: YMI) is a biopharmaceutical company that focuses on cancer patients. YMI stock is up 16% year-to-date and 127% in the last 12 months. Buy this stock
Investor Place · 6/30/2011
YM BioSciences Inc. (AMEX: YMI), said that, in view of the unusual market activity in the common stock of the Company, the NYSE Amex has contacted the Company in accordance with its usual practice. While it ordinarily does not comment on market …
StreetInsider · 11/22/2011
More from Bing News
Thus, it is advisable to trade in these stocks with caution. YM BioSciences Inc (AMEX: YMI) is a Canadian biotech firm with a market capitalization of $214 million. The stock rallied nearly 6 per cent on Friday but closed marginally down on a weekly basis.
Smallcap Network · ByBrian Prescott · 10/10/2011
YM BioSciences Inc. releases its open market trading $1.63. The company stock still off from the 52-week high of 1.74. YM BioSciences Inc. volume shares hit 190,078. YM Biosciences, Inc., a biopharmaceutical company, develops products primarily for the ...
TransWorldNews · 8/27/2009
YMI stock is up 16% year-to-date and 127% in the last 12 months. Buy this stock just under $3. As of this writing, Louis Navellier did not own a position in any of the stocks named here.
NASDAQ · 6/29/2011
Editor's note: This article is a stock pitch made by a member on CAPS ... NBIX ) ] have been much more successful with the move. After reading YMI's most recent earnings PR, I saw that they've completed the Sandbag maneuver they began about a year ago.
The Motley Fool · 11/22/2011
Access to the full company reports can be found the US healthcare reform law passed last year, brand-name biotech …
Yahoo Finance · 6/7/2011
Catalyst Pharmaceutical Partners CPRX, +6.69% shares rose 22% after the stock was initiated with a buy rating at Stifel Nicolaus with a $9 price target. C.H. Robinson Worldwide Inc. CHRW, +1.62% shares rose 22% after the company reported …
Market Watch · 1/31/2007
With shares of YM BioSciences (YMI) currently trading below $1.15 intraday ... of $4.6 million and just under 56 million shares of common stock outstanding with an average trading volume of just under 150,000 shares per day and minimal short interest ...
Seeking Alpha · ByMike Havrilla · 12/14/2007